Fabrice Jollant's research focuses on the cognitive and cerebral bases of vulnerability to suicide.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Pedro Rosa-Neto is interested in the structural changes that occur in the brain as a result of neurodegenerative disease.

Martin Lepage uses using functional magnetic resonance imaging (fMRI) to study memory deficits in patients with schizophrenia.

Alain Brunet, PhD, studies risk factors and develops effective treatments for PTSD, such as early intervention and reconsolidation blockade.

Jean-Bruno Debruille studies the processes that precede and permit the conscious perception using fMRI and ERPs.

Véronique Bohbot investigates the neural correlates underlying visual and auditory spatial memory in normal and brain-damaged individuals.

Jorge Armony, PhD conducts research on how the brain detects danger stimuli and how it interacts with consciousness and memory.

Watch this 2012 Mini-Psych school class "Preventing Alzheimer's Disease: an impossible dream?" by John Breitner